Emin Tamer Elkiran

Emin Tamer Elkiran

Auto-generated profile, based on publicly available information

Emin Tamer Elkiran

Inonu University,Faculty of Medicine, Department of Medical Oncology

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2007 in BMC Cancer
Verified
Journal Article
Open access
PDF file
EEEmin T Elkiran
Emin T Elkiran
NMNefsal Mar
Nefsal Mar
BABilge Aygen
Bilge Aygen
MGMehmet Ferit Gürsu
Mehmet Ferit Gürsu
AKAziz Karaoglu
Aziz Karaoglu
SKSüleyman Serdar KOCA
Süleyman Serdar KOCA
Lung cancer (LC) is the leading cause of cancer-related deaths. Oxidative DNA damage may contribute to the cancer risk. The antioxidant paraoxonase (PON1) is an endogenous free radical scavenger in the human body. The aim of this study was to determine serum PON1 and arylesterase (ARE) activities in patients with newly diagnosed LC.

1 January 2007 in Methods and Findings in Experimental and Clinical Pharmacology
Verified
Journal Article
Closed access
TET. Elkiran
T. Elkiran
HHH. Harputluoglu
H. Harputluoglu
UYU. Yasar
U. Yasar
MBM.O. Babaoglu
M.O. Babaoglu
Aysun DinçelAysun Dinçel
Aysun Dinçel
ABA. Bozkurt
A. Bozkurt
Cyclophosphamide (CPA) and adriamycin (ADR) are widely used drugs for cancer chemotherapy. It has been reported that CPA and ADR singly or in combination could alter activities of a variety of drug-metabolizing enzymes in animals via multiple mechanisms. However, the effects of CPA/ADR on drug metabolism are largely unknown in human beings. Losartan metabolism has been suggested as a marker for determination of CYP2C9 activity. Caffeine is a commonly used probe to assess the metabolic activities of CYP1A2, CYP2A6, N-acetyltransferase 2 (NAT2) and xanthine oxidase (XO). The present study was designed to analyze the effects of CPA/ADR on these drug-metabolizing enzymes by using losartan and caffeine as probe drugs. A single oral dose of 25 mg losartan and a cup of instant coffee was given to 15 breast cancer patients on three occasions (before, and 2-4 h and 3 weeks after the adjuvant CPA/ADR chemotherapy [600 mg CPA/m2/day, 60 mg ADR/m2/day]). Losartan, caffeine and their metabolites were analyzed by using high-pressure liquid chromatography. When compared with baseline, CYP1A2 activity was increased by 20% and CYP2C9 activity was decreased by 315% 3 weeks after the administration of CPA/ADR chemotherapy (p = 0.05). The chemotherapy did not change the activities of CYP2A6, NAT2 or XO. CPA/ADR treatment caused a differential effect on drug-metabolizing enzyme activities, and this may contribute to predicting the efficacy and toxicity of chemotherapeutics, as well as understanding the drug-drug interactions.

22 June 2012 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
EEEmin Tamer Elkiran
Emin Tamer Elkiran
AGAnatolian Society of Medical Oncology Group
Anatolian Society of Medical Oncology Group
MKMuhammet Ali Kaplan
Muhammet Ali Kaplan
ASAlper Sevinc
Alper Sevinc
SASercan Aksoy
Sercan Aksoy
SBSuleyman Buyukberber
Suleyman Buyukberber

25 December 2020 in Harran Üniversitesi Tıp Fakültesi Dergisi
Verified
Journal Article
Closed access
PDF file
TMTugba Menekli
Tugba Menekli
FDFerhan Doğan
Ferhan Doğan
EEEmin Tamer Elkiran
Emin Tamer Elkiran
Amaç: Bu araştırma kanserli hastalarda hastalık algısını ve yaşam kalitesini incelemek amacıyla tanımlayıcı olarak yapılmıştır.Materyal ve metod: Araştırmanın örneklemini Aralık 2019-Şubat 2020 tarihleri arasında bir eğitim araştırma hastanesinin onkoloji kliniğinde yatarak ve ayaktan tedavi gören 151 kanserli hasta oluşturmuştur. Veriler Kişisel Tanıtım Formu, Hastalık Algısı Ölçeği (HAÖ), Yaşam Kalitesi İndeksi –Kanser Versiyonu-III (QOL-CV) kullanılarak toplanmıştır. Veriler SPSS 25 programında tanımlayıcı istatistikler, Independent Samples t, Kruskal Wallis ve Mann- Whitney U ile değerlendirilmiştir.Bulgular: Hastaların % 58.3’ ünün kadın, %29.1’inin kolon kanseri olduğu ve %11.9’unun hastalık hakkında bilgi sahibi olmadığı bulunmuştur. HAÖ alt ölçeklerinden hastaların kişisel kontrol algısı puan ortalamasının (23.00 ± 3.35), QOL-CV alt ölçeklerinden ise aile alt ölçeği puan ortalamasının en yüksek (26.97±5.04) olduğu bulunmuştur. Toplam QOL-CV puan ortalaması ise 23.44±4.42 olarak saptanmıştır. Sonuç: Hastaların kişisel kontrol algısı ve yaşam kalitesi aile alt boyutu en yüksek, toplam yaşam kalitesi ise orta düzeydedir.

1 January 2021 in Cancer Treatment and Research Communications
Verified
Journal Article
Open access
AGahmet gulmez
ahmet gulmez
MDMustafa Dikilitas
Mustafa Dikilitas
EEEmin Tamer Elkiran
Emin Tamer Elkiran
HHHAKAN HARPUTLUOĞLU
HAKAN HARPUTLUOĞLU
Sunitinib malate is a multitargeted oral tyrosine kinase inhibitor (TKI) which is used in treatment of metastatic renal cell carcinoma with side effects such as diarrhea, mucositis, asthenia and myelosuppression. Serious toxicity associated with sunitinib is a rare situation. However; there are few cases reported in the literature. As a result of the inhibition that is caused by sunitinib malate agent at the receptor level, vascular endothelial growth factor (VEGF) level increases. These increased VEGF levels are considered to having a positive contribution on neurological side effects. Neurotoxicity that is related with the usage of sunitinib malate for two weeks will be presented in this case report.

1 January 2020 in Journal of Oncological Sciences
Verified
Journal Article
Open access
IÇİrFan Çi̇çİn
İrFan Çi̇çİn
AÇAydın ÇİLTAŞ
Aydın ÇİLTAŞ
SKSaadettin Kiliçkap
Saadettin Kiliçkap
BOBerna Oksuzoglu
Berna Oksuzoglu
DUDoğan Uncu
Doğan Uncu
MOMetin Ozkan
Metin Ozkan
For those who helped create the Genki Dama